Difference between revisions of "Nabilone (Cesamet)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | =Mechanism of action= | + | ==Mechanism of action== |
Synthetic cannabinoid with antiemetic properties. No known antineoplastic properties. | Synthetic cannabinoid with antiemetic properties. No known antineoplastic properties. | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand name:''' Cesamet | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| + | [[Category:Oral medications]] | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Cannabinoid]] | [[Category:Cannabinoid]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1985]] |
Latest revision as of 19:13, 30 July 2018
Mechanism of action
Synthetic cannabinoid with antiemetic properties. No known antineoplastic properties.
Also known as
- Brand name: Cesamet